Key findings from body composition studies include: Visceral fat (the deep abdominal fat surrounding organs) decreases alongside subcutaneous fat Studies suggest that approximately 60-75% of weight loss comes from fat mass, with the remainder from lean tissue [17] [18] Waist circumferencea proxy measure for abdominal obesitytypically reduces by 6-10 cm on average in clinical trials [8] [9] Improvements in metabolic parameters often occur alongside reductions in visceral fat It is worth noting that individual responses vary considerably
A., Zhao, J., McDaniel, J., Fjeldstad, A
Jenn heavily screens her clients to determine who should and shouldn't take them
For VOL.U.LIFT, we researched specific skin changes caused by GLP-1/GIP agonists, selected ingredients to address them, then completed clinical studies with current GLP-1/GIP users, explains Dr Ronert
Obesity can be treated in various ways ( Fig
With BrightTrack, we hope to give everyone the tools they need to stay consistent, understand their own progress, and feel supported on their journey."